Hamid Reza Kianifar; Yalda Rezaei; Ali Khakshour; Hassan Karami; Maryam Khalesi; Seyed Ali Jafari; Mohammad Ali kiani; Veda Vakili; Seyed Ali Alamdaran
Abstract
Cystic fibrosis-associated liver disease (CFLD) is an important aspect of cystic fibrosis (CF), which manifests with various signs and symptoms. Lack of specific examinations for CFLD have made the diagnostic process of the disease time-consuming, and the disease is often identified after severe progress. ...
Read More
Cystic fibrosis-associated liver disease (CFLD) is an important aspect of cystic fibrosis (CF), which manifests with various signs and symptoms. Lack of specific examinations for CFLD have made the diagnostic process of the disease time-consuming, and the disease is often identified after severe progress. Finding the associations between the outcomes of various clinical, biochemical, and sonography examinations could help specialists identify the disease in a timely manner. This review study aimed to determine the correlations between the outcomes of various diagnostic approaches based on the current literature. According to the literature, some studies have reported correlations between various diagnostic approaches, while other studies have reported no associations in this regard. This discrepancy could be due to the various manifestations associated with CF.
Negar Khalighi; Rahim Vakili; Mohammad Ali kiani; Seyed Ali Jafari; Hamid Reza Kianifar
Abstract
Introduction: Cystic fibrosis is one of the most common autosomal recessive diseases that affects sweat glands and mucosa. CF is a hereditary disease with annual incidence of about 2500 new cases in United Kingdom. Insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 ...
Read More
Introduction: Cystic fibrosis is one of the most common autosomal recessive diseases that affects sweat glands and mucosa. CF is a hereditary disease with annual incidence of about 2500 new cases in United Kingdom. Insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 levels decrease in CF. The aim of this study was to assess the role of growth peptides in patients with CF. Method: We searched PubMed, Google scholar, IranMedex, and Scientific Information Database (SID) in September 2012 to April 2014. We included clinical studies with available abstracts and full texts that were in English or Persian languages. Manual searching was conducted within the reference lists of articles. Two reviewers independently applied eligibility criteria, assessed quality, and extracted data.Result: The earliest study was published in 1997 and the most recent one was in 2014. Study participants were adults in 3 studies (20%) and 12 studies (80%) were conducted in children. Patients with CF have lower levels of IGF-1 and there is a significant correlation between IGF-1 levels and growth index in patients with CF.Conclusions: IGF-1 decreases in children with CF and might be the cause of poor growth and low body mass index in these children.